Replay available

Cabot Corporation (CBT) Q4 2025 Earnings Call

Cabot Corporation (NYSE: CBT) Q4 2025 earnings conference call, held 2025-11-04. Replay captured from the company's public earnings webcast.

Tue, November 4, 2025 at 8:00 AMendedReplay
Cabot Corporation (CBT) Q4 2025 Earnings Call

Investor webinar replay

Latest press releases

Companies on this event

Featured Presenters

Sean Cohen

President and CEO, Cabot Corporation

Kevin E. Stock

Analyst, Jefferies

Chris Perala

Analyst, UBS

Emily Fusco

Analyst, Deutsche Bank

Replay transcript excerpt

And then are you being impacted at all by Dow's silicone rationalization efforts in Europe? So as you know, Dow has announced the closure of their siloxanes plant in Barrie, Wales, and we have a fume silica plant. next door to them where we exchange some feedstock and materials as part of a long-term agreement that goes out through the end of 2028. And we're currently in discussions with Dow on exactly how they'll perform against that contract. Thank you. Thank you. One moment for our next question. Our next question comes from the line of David Begleiter with Deutsche Bank. Your line is open. Please go ahead. Hi, this is Emily Fusco on for Dave Begleiter. Maybe a question on tire contract prices. How much do you expect 2026 prices to be down or expectations by region? And maybe if you could give some color on what percentage of negotiations have been settled. Thank you. Sure. So what I can tell you is that we have completed roughly 25% of our contracts at this point, which is behind where we were at this time last year, where we were closer to 45% of the negotiations complete. And I think it's taking a little longer this year in part because everyone is having a difficult time trying to project exactly where they're demand expectations should be for 2026 given all of the turbulence. I can't comment on final outcomes here as we're obviously far from done and this is competitive information. Thank you and one moment for our next question. Our next question comes from the line of Joshua Spector with UBS. Your line is open. Please go ahead. Good morning. It's Chris Perala on for Josh. Could you elaborate on the, for the performance chemicals, the underlying assumptions that you have baked into the guidance for this year in terms of volume and growth, volume and price ex...

More from Cabot Corporation